Literature DB >> 21335515

Medicare reimbursement policies and hemodialysis vascular access outcomes: a need for change.

Michael Allon1, Lesley Dinwiddie, Eduardo Lacson, Derrick L Latos, Charmaine E Lok, Theodore Steinman, Daniel E Weiner.   

Abstract

In March 2010, the Center for Medicare and Medicaid Services (CMS) convened several clinical technical expert panels (C-TEP) to provide recommendations for improving various aspects of hemodialysis management. One of the C-TEPs was tasked with recommending measures to decrease vascular access-related infections. The members of this C-TEP, who are the authors of this manuscript, concluded unanimously that the single most important measure would be to remove financial and regulatory barriers to timely placement and revision of hemodialysis fistulas and the concurrent avoidance of catheter use. The following position paper outlines the financial barriers to improved vascular access outcomes and our proposals for a future CMS demonstration project.

Entities:  

Mesh:

Year:  2011        PMID: 21335515     DOI: 10.1681/ASN.2010121219

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  State medicaid coverage, ESRD incidence, and access to care.

Authors:  Manjula Kurella-Tamura; Benjamin A Goldstein; Yoshio N Hall; Aya A Mitani; Wolfgang C Winkelmayer
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

2.  Vascular access choice in incident hemodialysis patients: a decision analysis.

Authors:  David A Drew; Charmaine E Lok; Joshua T Cohen; Martin Wagner; Navdeep Tangri; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2014-07-25       Impact factor: 10.121

3.  Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.

Authors:  Kenneth J Woodside; Sarah Bell; Purna Mukhopadhyay; Kaitlyn J Repeck; Ian T Robinson; Ashley R Eckard; Sudipta Dasmunshi; Brett W Plattner; Jeffrey Pearson; Douglas E Schaubel; Ronald L Pisoni; Rajiv Saran
Journal:  Am J Kidney Dis       Date:  2018-02-09       Impact factor: 8.860

4.  Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications.

Authors:  Pietro Ravani; Robert Quinn; Matthew Oliver; Bruce Robinson; Ronald Pisoni; Neesh Pannu; Jennifer MacRae; Braden Manns; Brenda Hemmelgarn; Matthew James; Marcello Tonelli; Brenda Gillespie
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 8.237

5.  Re-envisioning Fistula First in a patient-centered culture.

Authors:  Amanda Gomes; Rebecca Schmidt; Jay Wish
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-06       Impact factor: 8.237

6.  The Making Dialysis Safer for Patients Coalition: A New Partnership to Prevent Hemodialysis-Related Infections.

Authors:  Priti R Patel; Kristin Brinsley-Rainisch
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-09       Impact factor: 8.237

7.  Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients.

Authors:  Luis A Coentrão; Carla S Araújo; Carlos A Ribeiro; Claúdia C Dias; Manuel J Pestana
Journal:  Perit Dial Int       Date:  2013-03-01       Impact factor: 1.756

8.  Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications.

Authors:  Hui Xue; Joachim H Ix; Weiling Wang; Steven M Brunelli; Michael Lazarus; Raymond Hakim; Eduardo Lacson
Journal:  Am J Kidney Dis       Date:  2012-11-16       Impact factor: 8.860

Review 9.  National agenda for prevention of healthcare-associated infections in dialysis centers.

Authors:  Neil Gupta; Marjory Cannon; Arjun Srinivasan
Journal:  Semin Dial       Date:  2013-05-20       Impact factor: 3.455

Review 10.  Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices.

Authors:  Bruce M Robinson; Tadao Akizawa; Kitty J Jager; Peter G Kerr; Rajiv Saran; Ronald L Pisoni
Journal:  Lancet       Date:  2016-05-22       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.